The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This...
Vous n'êtes pas connecté
The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This designation is given to medical devices that hold the potential to offer substantial improvements […]
The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This...
Neuralink announced this morning that they have received FDA approval to test a new implant that will allow blind people to see again. The Blindsight...
Neuralink announced this morning that they have received FDA approval to test a new implant that will allow blind people to see again. The Blindsight...
Elon Musk says device will restore people?s sight.
Novartis announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI)...
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...
WASHINGTON, USA – On Thursday, the US Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing...
WASHINGTON, USA – On Thursday, the US Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing...
The FDA bestows an orphan drug designation to Agios' PK activator, tebapivat, for treating myelodysplastic syndromes.